In this episode of the VBCA Podcast, Alex Yarijanian sits down with Dr. Kumar Dharmarajan — co-founder and Chief Medical Officer of World Class Health and former Chief Scientific and Medical Officer at Clover Health — to unpack one of the most important structural differences in U.S. healthcare: incentive alignment.

Why are employers often paying two to four times Medicare rates for identical procedures performed in the same hospital by the same physician?

The answer isn’t clinical complexity. It’s incentive design.

Dr. Kumar breaks down how Medicare Advantage plans negotiate as owners of financial risk — and why that matters. In contrast, much of the commercial self-insured market relies on administrators who negotiate without full downside exposure, creating a structural pricing gap.

The conversation also explores:

1. What Medicare Advantage plans are actually looking for when contracting with digital health and AI solutions
2. Why engagement — not automation — is the real leverage point
3. The economics of supplemental benefits and underutilized Star opportunities
4. Home-based and remote care as risk containment strategies
5. The future vision of standardized specialty care marketplaces

This is a structural conversation about incentives, risk ownership, and where execution truly matters in value-based care.

1. Incentive alignment drives pricing discipline. Medicare Advantage plans negotiate differently because they own the full medical loss ratio.
2. Commercial self-insured markets often lack that same alignment, contributing to higher negotiated rates.
3. AI in Medicare Advantage is less about backend efficiency and more about member activation and physician-level quality improvement.
4. Underutilized supplemental benefits represent unrealized revenue and quality movement.
5. Home-based and remote care models are fundamentally about managing high-acuity risk, not convenience.

00:00 – Introduction

01:39 – What Medicare Advantage plans actually want from AI vendors

03:27 – Why engagement infrastructure is the real leverage point

04:28 – Virtual care, socioeconomic complexity, and risk ownership

06:18 – High-acuity members and access-driven cost escalation

07:11 – Supplemental benefits and engagement economics

08:36 – Stars, utilization, and revenue implications

09:55 – Employers paying 2–4x Medicare rates

10:27 – Why commercial pricing diverges

12:17 – Incentive structure and negotiation power

12:47 – Vision for standardized specialty care marketplaces

Dr. Kumar Dharmarajan is a practicing cardiologist and geriatrician and the co-founder and Chief Medical Officer of World Class Health. He previously served as Chief Scientific and Medical Officer at Clover Health and was on faculty at Yale School of Medicine, where his research helped shape national post-acute care quality measures. He has published in the New England Journal of Medicine, JAMA, and Health Affairs.

Companies mentioned in this episode:

1. World Class Health
2. Clover Health

CMS is moving tens of billions of dollars into every state to stabilize rural healthcare heading into 2026—not through across-the-board rate increases, but through targeted investments in workforce, technology, care coordination, and alternative payment models.

In this episode, Alex Yarijanian breaks down what the Rural Health Transformation Program / Rural Health Fund (RHTF) actually is, what state strategies reveal about the future of rural access, and why this matters far beyond rural hospitals—impacting payer strategy, provider contracting, network adequacy, and healthcare economics.

You’ll hear key highlights from state plans including California, Texas, Florida, New York, and Illinois, plus the cross-state themes showing up everywhere: hub-and-spoke models, shared services, EMS reform, telehealth hubs, and AI-driven admin reduction (including automated fax processing).

1. What the Rural Health Transformation Program actually is
2. Why this funding wave is different (state plans are concrete and approved)
3. What state strategies reveal about access risk + reimbursement limits
4. How payers should interpret this as a network adequacy / access signal
5. Why providers should see this as both opportunity + accountability shift

California

1. Hub-and-spoke maternal + specialty access models
2. Example of rate + infrastructure working together (Health Plan of San Mateo specialty rate increases)

Texas

1. Technology as a force multiplier
2. AI-enabled specialty access, telehealth coordination, clinically integrated networks
3. Tech becomes a parallel lever to reimbursement in high-dispute markets

Florida

1. Remote patient monitoring (RPM) + community paramedicine
2. Utilization management upstream in MA-heavy environments

New York

1. Patient-centered medical homes + workforce pipelines
2. Care coordination over unit cost expansion in concentrated payer markets

Illinois

1. Integrated primary + behavioral health infrastructure
2. EMS treat-not-transport models
3. Alternative models as a response to inflation vs lagging rates

1. Hub-and-spoke models are returning at scale
2. Shared services (centralized EHR, billing, analytics) to reduce admin burden
3. AI as infrastructure (clinical decision support + operational efficiency)
4. Specific AI use cases being funded:
5. Automated fax processing
6. AI scribes
7. AI-enabled care coordination

Rural health stabilization strategy is not uniform across states — but the goal is consistent: protect access where reimbursement alone hasn’t been enough.

Mentioned in this episode:

1. Health plan of San Mateo
2. California
3. Texas
4. Florida
5. New York
6. Illinois
7. Oklahoma
8. Washington
9. Utah
10. Vermont

While most providers are waiting on CMS, payers are already narrowing networks and rewriting delegation terms.

Payers are quietly narrowing networks and rewriting delegation expectations. This playbook explains how to do business with MA business for 2026.

If you’re waiting, you’re already reacting—not positioning.

In this episode, Alex Yarijanian breaks down what’s actually showing up in payer conversations right now, long before final CMS rules are published. Drawing from real contracting, network, and delegation discussions, Alex explains why waiting for regulatory clarity is already costing providers and health tech companies leverage.

You’ll hear how payer priorities have shifted from enrollment growth to margin durability, why network narrowing is accelerating quietly, how delegation has become a stress test, and what “value-based care” really means in Medicare Advantage today.

This episode also outlines who is most at risk heading into 2026, the three types of organizations positioned to win, and what provider and health tech leaders should do in the next 90 days to stay relevant.

Who should listen: Provider executives, payer leaders, value-based care operators, and health tech founders navigating Medicare Advantage.